Evidence map›Paper›PMID 39040334›Full record

ReviewHeliyon2024

Programmed cell death, from liver Ischemia-Reperfusion injury perspective: An overview.

Shaobin Luo, Rongkun Luo, Gang Deng, Feizhou Huang, Zhao Lei

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shaobin LuoDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South University, Changsha , PR China.
Rongkun LuoDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South University, Changsha , PR China.
Gang DengDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South University, Changsha , PR China.
Feizhou HuangDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South University, Changsha , PR China.
Zhao LeiDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South University, Changsha , PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver ischemia-reperfusion injury (LIRI) commonly occurs in liver resection, liver transplantation, shock, and other hemorrhagic conditions, resulting in profound local and systemic effects via associated inflammatory responses and hepatic cell death. Hepatocyte death is a significant component of LIRI and its mechanism was previously thought to be limited to apoptosis and necrosis. With the discovery of novel types of programmed cell death (PCD), necroptosis, ferroptosis, pyroptosis, autophagy, NETosis, and parthanatos have been shown to be involved in LIRI. Understanding the mechanisms underlying cell death following LIRI is indispensable to mitigating the widespread effects of LIRI. Here, we review the roles of different PCD and discuss potential therapy in LIRI.

Indexed as

ApoptosisAutophagyFerroptosisLiver ischemia-reperfusion injuryProgrammed cell death

Identifiers

PMID39040334
PMCPMC11260932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.